KPIs for ESG - DVFA
KPIs for ESG - DVFA
KPIs for ESG - DVFA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4573 Biotechnology<br />
<strong>ESG</strong> KPI KPI-Label + Definition<br />
2742 Energy Efficiency E0101 Energy consumption, total<br />
2743 Energy Efficiency E0102 Energy consumption, specific (intensity); Options: per unit of<br />
revenue, per FTE, per unit of production volume (e.g. tonnes of steel)<br />
2744 GHG Emissions E0201 GHG emissions, total (scope I,II, III)<br />
2745 GHG Emissions E0202 GHG emissions, specific; Options: per unit of revenue, per<br />
FTE, per unit of production volume (e.g. tonnes of steel)<br />
2746 Staff Turnover S0101 Percentage of FTEs leaving p.a./total FTEs<br />
2747 Training & Qualification S0202 Average expenses on training per FTE p.a<br />
2748 Maturity of Work<strong>for</strong>ce S0301 Age structure/distribution (number of FTEs per age group, 10-year intervals)<br />
2749 Remuneration S0801 Total amount of bonuses, incentives and stock options paid out in €,$<br />
2750 Remuneration S0802 Total number of FTEs who receive 90 % of total amount of bonuses, incentives and stock options<br />
2751 Remuneration S0803 Key Per<strong>for</strong>mance Narrative (Please answer the questions in max. 500 words) Do you take <strong>ESG</strong><br />
per<strong>for</strong>mance into account in your per<strong>for</strong>mance agreements? How do you integrate <strong>ESG</strong> principles<br />
within per<strong>for</strong>mance agreements in your company and to what extent do you apply them?<br />
2752 Litigation risks V0101 Expenses and fines on filings, law suits related to anti-competitive<br />
behavior, anti-trust and monopoly practices<br />
2753 Corruption V0201 Percentage of revenues in regions with Transparency International corruption index below 6.0<br />
2754 Revenues from new<br />
products<br />
V0302 Percentage of new products or modified products introduced less<br />
than 12 months ago<br />
2755 Innovation V0401 Total R&D expenses<br />
2756 Innovation V0402 Total R&D expenses in monetary terms i.e. currency as a percentage of total revenue<br />
2757 Innovation V0403 Total R&D expenses or funding of research to external partners, suppliers or academic research in<br />
monetary terms i.e. currency<br />
2758 Innovation V0403 Total R&D expenses or funding of research to external partners, suppliers or academic research in<br />
monetary terms i.e. currency<br />
2759 Innovation V0405 Number of patents registered within last 12 month<br />
2760 Innovation V0406 Percentage of patents registered within last 12 month in relation to total number of patents<br />
2761 Innovation V0407 Number of patents due to expire within next 12 month in relation to total number of patents<br />
2762 Innovation V0408 Percentage of patents due to expire within next 12 month in relation to total number of patents<br />
2763 Innovation V0412 Total investments in research on <strong>ESG</strong>-relevant aspects of business such as e.g. eco-design, ecoefficient<br />
production processes, decreasing impact on biodiversity, improving health and safety<br />
conditions of employees or supply chain partners, consulting on integration of <strong>ESG</strong> aspects in change<br />
management, development of products to exploit <strong>ESG</strong> opportunities etc. in monetary terms i.e.<br />
currency as a percentage of revenue<br />
2764 Innovation V0413 Percentage of products or services <strong>for</strong><br />
- increasing eco-efficiency of client applications or operations<br />
- developing and using clean technologies<br />
- offsetting climate change, carbon emissions , resource depletion<br />
- increasing fuel-efficiency<br />
- making <strong>ESG</strong>-relevant products operable<br />
(e.g. smart metering, green building technologies)<br />
- financing of <strong>ESG</strong>-relevant products or services<br />
2765 Waste Scope III E0601 Hazardous waste total in tonnes total<br />
2766 Waste Scope III E0606 Non-hazardous waste total in tonnes total<br />
2767 Radioactive Waste E0801 Low Level Waste (by definition of U.S. Atomic Energy Act) produced in tonnes p.a.<br />
2768 Radioactive Waste E0802 Intermediate Level Waste (by definition of U.S. Atomic Energy Act) produced in tonnes p.a.<br />
2769 Radioactive Waste E0803 High Level Waste (by definition of U.S. Atomic Energy Act) produced in kg p.a.<br />
2770 Radioactive Waste E0804 Transuranic Waste (by definition of U.S. Atomic Energy Act) produced in kg p.a.<br />
2771 Radioactive Waste E0805 Radioactive waste subjected to reprocessing by Waste Level (LLW,ILW,HLW,TRUW) in tonnes<br />
2772 Radioactive Waste E0806 Radioactive waste stored at company property by Waste Level (LLW, ILW, HLW, TRUW) in tonnes<br />
2773 Eco-Design E1308 Amount of hazardous / non biodegradable products (after use and if unused)<br />
2774 Production Shortfall E2301 Production shortfall caused by material supply constraints in percent (gap between actual production<br />
output and theoretical production output as optimal supply)<br />
2775 Production Shortfall E2302 Monetary impact of production shortfall caused by material supply constraints in monetary terms i.e.<br />
currency<br />
2776 Water Consumption E2801 Water consumption in m³<br />
2777 Environmental Compatibility E3301 Number of sites with ISO 14001 certification / number of total sites<br />
2778 Contributions to political<br />
parties<br />
G0101 Contributions to political parties as a percentage of total revenues<br />
2779 Product Withdrawals G0301 Number and amount of product withdrawn from market due to regulatory pressure<br />
2780 Health & Safety Aspects of<br />
Products<br />
S0501 Total spending on product safety corporate as a percentage of revenue corporate<br />
2781 Utilisation V1301 Capacity utilisation as a percentage of total available facilities<br />
2782 Supply Chain V2801 Total number of suppliers<br />
2783 Supply Chain V2802 Percentage of sourcing from 3 biggest external suppliers<br />
© <strong>DVFA</strong> April 2010 ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any <strong>for</strong>m or by any means, electronic,<br />
mechanical, recording, without the prior permission of the copyright holder.<br />
113